MP CARDIOFLOW-B(02160) is advised to implement a share consolidation.

18:39 26/01/2026

Minimally Invasive Heartlink-B (02160) announced that the board of directors has recommended a consolidation of the company's share capital, combining every 5 existing and unissued shares with a face value of $0.000005 US dollars each into 1 consolidated share with a face value of $0.000025 US dollars per share.

MP CARDIOFLOW-B (02160) announced that the Board of Directors recommends a consolidation of the company's share capital, combining every 5 existing issued and unissued shares with a par value of $0.000005 per share into 1 share with a par value of $0.000025 per share. As of the date of this announcement, existing shares are traded in board lots of 1,000 shares on the Stock Exchange. After the share consolidation takes effect, the board lot size for trading on the Stock Exchange will remain at 1,000 shares of consolidated stock.

CF PHARMTECH (02652) spent 382,900 Hong Kong dollars to repurchase 11,000 shares on January 26th.

"Shenwan Hongyuan Group (06806): The "25 Shen D11" will be redeemed and delisted on January 23rd."

PW MEDTECH (01358) spent 137,000 Hong Kong dollars repurchasing 106,000 shares on January 26.

CF PHARMTECH (02652) spent 382,900 Hong Kong dollars to repurchase 11,000 shares on January 26th.

"Shenwan Hongyuan Group (06806): The "25 Shen D11" will be redeemed and delisted on January 23rd."

PW MEDTECH (01358) spent 137,000 Hong Kong dollars repurchasing 106,000 shares on January 26.